Liver Steatoses Clinical Trials
3 recruiting trials for Liver Steatoses. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Liver Steatoses clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Anton Skaro (1), Beijing Jishuitan Hospital (1), Medical College of Wisconsin (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Ketogenic Diet (dietary_supplement, 1 trial), followed by outpatient evaluation of fatty liver.
Track Liver Steatoses trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis
Non-alcoholic fatty liver disease is becoming increasingly common in Canada and throughout the world. Fatty liver can increase the risks of perioperative complications for those...
China Health Big Data
In this nationwide multi center study the investigators combine the low dose chest CT scan data with QCT technology, to measure the BMD of spine, VAT and liver fat in the health...
Diagnosis of Fatty Liver With Outpatient Ultrasound
This study will evaluate whether ultrasound performed during outpatient visit is effective in early diagnosis of fatty liver.
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Liver Steatoses, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Liver Steatoses, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Liver Steatoses, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.